Literature DB >> 19998323

Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders.

S K Kulkarni1, Ashish Dhir.   

Abstract

Berberine, an isoquinoline alkaloid of the protoberberine type found in an array of plants, has been used in Indian and Chinese medicines as an antimicrobial, stomachic, bitter tonic and in the treatment of oriental sores. Although pharmacological investigations of berberine have been reported by many in the past, there is renewed interest in berberine because of its reported beneficial effect in various neurodegenerative and neuropsychiatric disorders. The alkaloid is reported to modulate neurotransmitters and their receptor systems in the brain. This review attempts to discuss the pharmacological basis of the use of berberine in various central nervous system and related disorders. Its protective effect in Alzheimer's, cerebral ischemia, mental depression, schizophrenia and anxiety are highlighted. However, more detailed clinical trials along with a safety assessment of berberine are warranted for positioning the alkaloid in the treatment of neurological disorders. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19998323     DOI: 10.1002/ptr.2968

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  68 in total

1.  Berberine promotes axonal regeneration in injured nerves of the peripheral nervous system.

Authors:  Ah Mi Han; Hwon Heo; Yunhee Kim Kwon
Journal:  J Med Food       Date:  2012-02-08       Impact factor: 2.786

2.  Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats.

Authors:  Hamid Kalalian Moghaddam; Tourandokht Baluchnejadmojarad; Mehrdad Roghani; Mehdi Khaksari; Pirasteh Norouzi; Malihea Ahooie; Fatemeh Mahboobi
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

3.  Berberine protects homocysteic acid-induced HT-22 cell death: involvement of Akt pathway.

Authors:  Meihui Chen; Min Tan; Minghua Jing; Anmin Liu; Qinyu Liu; Shijun Wen; Ziwei Chen; Xiaojuan Chao; Xixin He; Charles Ramassamy; Youheng Gao; Rongbiao Pi
Journal:  Metab Brain Dis       Date:  2014-07-23       Impact factor: 3.584

4.  Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation.

Authors:  Jun-Rong Zhu; Hai-Dan Lu; Chao Guo; Wei-Rong Fang; Hong-Dong Zhao; Jun-Shan Zhou; Feng Wang; Yan-Li Zhao; Yun-Man Li; Ying-Dong Zhang; Chang-Qing Yang; Jian-Guo Sun
Journal:  Acta Pharmacol Sin       Date:  2018-11       Impact factor: 6.150

5.  Coptidis Rhizoma-Contained Traditional Formulae for Insomnia: A Potential to Prevent Diabetes?

Authors:  Wen-Ya Huang; Hui Dong
Journal:  Chin J Integr Med       Date:  2018-09-29       Impact factor: 1.978

Review 6.  Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury.

Authors:  Peng-fei WU; Zui ZHANG; Fang WANG; Jian-guo CHEN
Journal:  Acta Pharmacol Sin       Date:  2010-12       Impact factor: 6.150

7.  Dose-response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice.

Authors:  Ying Guo; Chad Pope; Xingguo Cheng; Honghao Zhou; Curtis D Klaassen
Journal:  J Ethnopharmacol       Date:  2011-09-06       Impact factor: 4.360

8.  Pharmacologic preconditioning with berberine attenuating ischemia-induced apoptosis and promoting autophagy in neuron.

Authors:  Qichun Zhang; Huimin Bian; Liwei Guo; Huaxu Zhu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 9.  Traditional Chinese medicine and Western psychopharmacology: building bridges.

Authors:  Edward Shorter; Kathryn Segesser
Journal:  Phytother Res       Date:  2013-02-17       Impact factor: 5.878

10.  Berberine alleviates amyloid β25-35-induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors.

Authors:  Jing Xu; Wenlan Wu; Hong Zhang; Li Yang
Journal:  Exp Ther Med       Date:  2018-09-17       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.